Aligos Therapeutics, Inc. ( ALGS) - Key Metrics
ALGS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.02 | -$1.91 | -$2.09 | -$2.10 |
| 2025Q3 | $0.07 | -$3.04 | -$2.35 | -$2.37 |
| 2025Q2 | $0.09 | -$1.53 | -$1.50 | -$1.51 |
| 2025Q1 | $0.04 | $5.12 | -$2.49 | -$2.49 |
ALGS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.22 |
| 2025Q3 | ? | -0.81 |
| 2025Q2 | ? | -1.18 |
| 2025Q1 | ? | 0.40 |
ALGS Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -30.01% | ? |
| 2025Q4 | -22.56% | ? |
| 2025Q3 | -24.15% | ? |
| 2025Q2 | -20.92% | ? |
| 2025Q1 | -30.20% | ? |
ALGS
Price: $5.28
52 week price:
Earnings Per Share: -9.78 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 78576
Market Capitalization: 31.8 million